Corticotropin-releasing hormone receptor subtypes and emotion

Biological Psychiatry

Volumn 46, Issue 11, 1999, Pages 1480-1508

  Steckler, Thomas ^a   Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Anxiety; Cognition; Corticotropin releasing factor (CRH); CRH receptor subtypes; Emotion; Motivation

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR 2ALPHA RECEPTOR; CORTICOTROPIN RELEASING FACTOR 2BETA RECEPTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL MODEL; ANXIETY; ATTENTION; BEHAVIOR; COGNITION; CONFERENCE PAPER; DEFENSIVE BEHAVIOR; DEPRESSION; EATING DISORDER; EMOTION; FEEDING BEHAVIOR; GENE EXPRESSION; HUMAN; KNOCKOUT MOUSE; LEARNING; MEMORY; MENTAL DISEASE; MOTIVATION; MUTANT; NEUROANATOMY; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; SEXUAL BEHAVIOR; STRESS; SURVIVAL; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; EMOTIONS; HUMANS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 0032751399     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00170-5     Document Type: Conference Paper

References (167)

1. Aguilera G., Harwood J.P., Wilson J.T., Marcell J., Brown J.H., Cas H.J.T. Mechanism of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells. J Biol Chem. 258:1983;8039-8045.
2. Ambrosio E., Sharpe L.G., Pilotte N.S. Regional binding to corticotropin releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal. Synapse. 25:1997;272-276.
3. Arai K., Ohata H., Shibasaki T. Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1 . Neurosci Lett. 255:1998;103-106.
4. Austin M.C., Rice P.M., Mann J.J., Arango V. Localization of corticotropin-releasing hormone in the human locus coeruleus and pedunculopontine tegmental nucleus an immunocytochemical and in situ hybridization study . Neuroscience. 64:1995;713-727.
5. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol. 179:1978;641-668.
6. Baker D.G., West S.A., Nicholson W.E., Ekhator N.N., Kasckow J.W., Hill K.K., et al. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiat. 156:1999;585-588.
7. Bandler R., Shipley M.T. Columnar organization in the midbrain periaqueductal gray modules for emotional expression? Trends Neurosci. 17:1994;379-389.
8. Behan D.P., De Souza E.B., Lowry P.J., Potter E., Sawchenko P., Vale W.W. Corticotropin releasing factor (CRF) binding protein a novel regulator of CRF and related peptides . Frontiers Neuroendocrinol. 16:1995;362-382.
9. Behan D.P., Heinrichs S.C., Troncoso J.C., Liu X.J., Kawas C.H., Ling N., et al. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature. 378:1995;284-287.
10. Bornstein S.R., Webster E.L., Torpy D.J., Richman S.J., Mitsiades N., Igel M., et al. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Endocrinology. 139:1998;1546-1555.
11. Bradley K.N., Albert D.J. Suppression of VMH-lesion-induced reactivity and aggressiveness in the rat by stimulation of lateral septum, but not medial septum or cingulate cortex. J Comp Physiol Psychol. 91:1977;290-299.
12. Burns L.H., Robbins T.W., Everitt B.J. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine. Behav Brain Res. 55:1993;167-183.
13. Butler P.D., Weiss J.M., Stout J.C., Nemeroff C.B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci. 10:1990;176-183.
14. Cador M., Robbins T.W., Everitt B.J. Involvement of the amygdala in stimulus-reward associations interactions with the ventral striatum . Neuroscience. 30:1989;77-86.
15. Canteras N.S., Simerly R.B., Swanson L.W. Organization of the projections from the medial nucleus of the amygdala a PHAL study in the rat . J Comp Neurol. 360:1995;213-245.
16. Carli M., Robbins T.W., Evenden J.L., Everitt B.J. Effects of lesions to ascending noradrenergic neurons on performance on a 5-choice serial reaction time task in rats implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal . Behav Brain Res. 9:1983;361-380.
17. 1 receptor mRNA expression . J Neurosci. 15:1995;6340-6350.
18. Champagne D., Beaulieu J., Drolet G. CRFergic innervation of the paraventricular nucleus of the rat hypothalamus a tract-tracing study . Eur J Neurosci. 10:1998;119-131.
19. Chang F.C., Opp M.R. Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat. Am J Physiol. 275:1998;R793-R802.
20. Cole B.J., Robbins T.W. Forebrain norepinephrine role in controlled information processing in the rat . Neuropsychopharmacology. 7:1992;129-142.
21. Coplan J.D., Lydiard R.B. Brain circuits in panic disorder. Biol Psychiatry. 44:1998;1264-1276.
22. Crawley J.N., Olschowska J.A., Diz D.I., Jacobowitz D.M. Behavioral investigation of the co-existence of substance P, corticotropin-releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex in rats. Peptides. 6:1985;891-901.
23. Cullinan W.E., Herman J.P., Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus evidence for a relay in the bed nucleus of the stria terminalis . J Comp Neurol. 332:1993;1-20.
24. Cummings S., Sharp B., Elde R. Corticotropin-releasing factor in cerebellar afferent systems a combined immunohistochemistry and retrograde transport study . J Neurosci. 8:1988;543-554.
25. Day J.C., Koehl M., Le Moal M., Maccari S. Corticotropin-releasing factor administered centrally, but not peripherally, stimulates hippocampal acetylcholine release. J Neurochem. 71:1998;622-629.
26. Day J.C., Koehl M., Deroche V., Le Moal M., Maccari S. Prenatal stress enhances stress- and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release. J Neurosci. 18:1998;1886-1892.
27. Deak T., Nguyen K.T., Ehrlich A.L., Watkins L.R., Spencer R.L., Maier S.F., et al. the impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology. 140:1999;79-86.
28. Deakin J.F., Graeff F.G. 5-HT and mechanisms of defence. J Psychopharmacol. 5:1991;305-315.
29. De Bold C.R., Sheldon W.R., De Cherney G.S., Jackson R.V., Alexander A.N., Vale W., et al. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest. 13:1984;533-538.
30. De Oca B.M., De Cola J.P., Maren S., Fanselow M.S. Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses. J Neurosci. 18:1998;3426-3432.
31. De Souza E.B. Corticotropin-releasing factor receptors physiology, pharmacology, biochemistry and role in central nervous system and immune disorders . Psychoneuroendocrinol. 20:1995;789-819.
32. De Souza E.B., Battaglia G. Increased corticotropin-releasing factor receptors in rat cerebral cortex following chronic atropine treatment. Brain Res. 397:1986;401-404.
33. De Souza E.B., Whitehouse P.J., Kuhar M.J., Price D.L., Vale W.W. Reciprocal changes in corticotropin-releasing factor immunoreactivity and CRF receptors in cerebral cortex of Alzheimer' disease. Nature. 319:1986;593-595.
34. De Souza E.B., Whitehouse P.J., Kuhar M.J., Price D.L., Vale W.W. Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders. Ann NY Acad Sci U S A. 512:1987;237-247.
35. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., et al. Cloning and characterization of human urocortin. Endocrinology. 137:1996;2167-2170.
36. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration is CRF a mediator of anxiety or stress responses? Brain Res Rev. 15:1990;71-100.
37. 2) in hypothalamus and amygdala of the immature rat by sensory input and food intake. J Neurosci. 19:1999;3982-3991.
38. Eghbal-Ahmadi M., Hatalski C.G., Avishai-Eliner S., Baram T.Z. Corticotropin releasing factor type II (CRF2) mesenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation. Endocrinology. 138:1997;5048-5051.
39. Ehlers C.L., Reed T.K., Heniksen S.J. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activation in rats. Neuroendocrinology. 42:1986;467-474.
40. Erb S., Shaham Y., Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci. 18:1998;5529-5536.
41. Fleming A.S., Vaccarino F., Luebke C. Amygdaloid inhibition of maternal behavior in the nulliparous female rat. Physiol Behav. 25:1980;731-745.
42. Gallagher M., Holland P.C. The amygdala complex multiple roles in associative learning and attention . Proc Natl Acad Sci U S A. 91:1994;11771-11776.
43. García-Rill E. The pedunculopontine nucleus. Progr Neurobiol. 36:1991;363-389.
44. Giardino L., Puglisi-Allegra S., Ceccatelli S. CRH-R1 mRNA expression in two strains of inbred mice and its regulation after repeated restraint stress. Mol Brain Res. 40:1996;310-314.
45. Gray T.S. Autonomic neuropeptide connections of the amygdala. Tache Y., Morley J.E., Brown M. Neuropeptides and Stress Symposia Hans Seyle . 1989;92-106 Springer, Heidelberg.
46. Gray T.S. The organization and possible function of amygdaloid corticotropin-releasing factor pathways. De Souza E.B., Nemeroff C.B. Corticotropin-Releasing Factor Basic and Clinical Studies of a Neuropeptide . 1990;53-68 CRC, Boca Raton, FL.
47. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann NY Acad Sci. 697:1993;53-60.
48. Gray T.S., Bingaman E.W. The amygdala corticotropin-releasing factor, steroids, and stress . Crit Rev Neurobiol. 10:1996;155-168.
49. Griebel G., Perrault G., Sanger D.J. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology. 138:1998;55-66.
50. Gunion M.W., Kauffman G.L., Tache Y. Intrahypothalamic corticotropin-releasing factor elevates gastric bicarbonate and inhibits stress ulcers in rats. Am J Physiol. 258:1990;G152-G157.
51. Hatfield T., Han J.S., Conley M., Gallagher M., Holland P. Neurotoxic lesions of basolateral, but not central, amygdala interfere with pavlovian second-order conditioning and reinforcer devaluation effects. J Neurosci. 16:1996;5256-5265.
52. Heinrichs S.C., Lapsansky J., Lovenberg T.W., De Souza E.B., Chalmers D.T. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regul Peptides. 71:1997;15-21.
53. Heinrichs S.C., Menzaghi F., Schulteis G., Koob G.F., Stinus L. Suppression of corticotropin-releasing factor in the amygdala attentuates aversive consequences of morphine withdrawal. Behav Pharmacol. 6:1995;74-80.
54. Heinrichs S.C., Min H., Tamraz S., Carmouche M., Boehme S.A., Vale W.W. Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinol. 22:1997;215-224.
55. Heinrichs S.C., Stenzel-Poore M.P., Gold L.H., Battenberg E., Bloom F.E., Koob G., et al. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience. 74:1996;303-311.
56. Heinrichs S.C., Vale E.A., Lapsansky J., Behan D.P., McClure L.V., Ling N., et al. Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. Peptides. 18:1997;711-716.
57. Herman J.P., Cullinam W.E., Young E.A., Akil H., Watson S.J. Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CH) and arginine vasopressin (AVP) mRNA expression. Brain Res. 592:1992;228-238.
58. Holahan M.R., Kalin N.H., Kelley A.E. Microinfusion of corticotropin-releasing factor into the nucleus accumbens shell results in increased behavioral arousal and oral motor activity. Psychopharmacology. 130:1997;189-196.
59. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiat Res. 33:1999;181-214.
60. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Rev. 17:1996;187-205.
61. Holsboer F., Gerken A., von Bardeleben U., Grimm W., Beyer H., Müller O.A., Stalla G.K. Human corticotropin-releasing hormone in depression. Biol Psychiatry. 21:1986;601-611.
62. Hotta M., Shibasaki T., Arai K., Demura H. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res. 823:1999;221-225.
63. Imaki T., Shibasaki T., Masuda A., Shizume K., Ling N. The antagonistic effect of corticotropin-releasing factor on pentobarbital in rats. Brain Res. 383:1986;323-326.
64. Inglis F.M., Day J.C., Fibiger H.C. Enhanced acetylcholine release in hippocampus and cortex durring the anticipation and consumption of a palatable meal. Neuroscience. 62:1994;1049-1064.
65. Jones D.N.C., Kortekaas R., Slade P.D., Middlemiss D.N., Hagan J.J. The behavioural effects of corticotropin-releasing factor-related peptides in rats. Psychopharmacology. 138:1998;124-132.
66. Kalivas P.W., Duffy P., Latimer L.G. Neurochemical and behavioral effects of coricotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther. 242:1987;757-764.
67. Koob G.F. Drug addiction the yin and yang of hedonic homeostasis . Neuron. 16:1996;893-896.
68. Kozicz T., Yanaihara H., Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol. 391:1998;1-10.
69. Krahn D.D.B.A., Gosnell S.A., Levine S.A., Morley J.E. Behavioral effects of corticotropin-releasing factor localization and characterization of central effects . Brain Res. 443:1988;63-69.
70. Lacroix S., Rivest S. Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain. J Cem Neuroanat. 10:1996;53-71.
71. LeDoux JE (1996): The Emotional Brain. Simon & Schuster, New York.
72. LeDoux J.E. Emotional networks and motor control a fearful view . Prog Brain Res. 107:1996;437-446.
73. LeDoux J. Fear and the brain where have we been, and where are we going? Biol Psychiatry. 44:1998;1229-1238.
74. Lee E.H.Y., Hung H.C., Lu K.T., Chen W.H., Chen H.Y. Protein synthesis in the hippocampus associated with memory facilitation by corticotropin-releasing factor in rats. Peptides. 13:1992;927-937.
75. Lee Y., Davis M. Role of the septum in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci. 15:1997;6424-6433.
76. Lee Y., Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci. 17:1997;6434-6445.
77. Lee S., Rivier C. Alcohol increases the expression of type 1, but not type 2α corticotropin-releasing factor (CRF) receptor messenger ribonucleic acid in the rat hypothalamus. Mol Brain Res. 52:1997;78-89.
78. Leibowitz S.F., Alexander J.T. Hypothalamic serotonin in the control of eating behavior, meal size, and body weight. Biol Psychiatry. 44:1998;851-864.
79. Liebsch G, Landgraf R, Engelmann M. Lörscher P, Holsboer F (in press): Differential behavioural effects of chronic infusion of CRH1 and CRH2 receptor antisense oligonucleotides into the rat brain. J Psychiat Res.
80. 1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Peptides. 59:1995;301-310.
81. 2β receptor mRNAs are differntially distributed between the rat central nervous system and peripheral tissues. Endocrinology. 136:1995;4139-4143.
82. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA. 92:1995;836-840.
83. Lucki I. The spectrum of behaviors influences by serotonin. Biol Psychiatry. 44:1998;151-162.
84. Lundkvist J., Chai Z., Teheranian R., Hasanvan H., Bartfai T., Jenck F., et al. A non-peptidic coticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol. 309:1996;195-200.
85. Maaswinkel H., Baars A.M., Gispen W.H., Spruijt B.M. Roles of the basolateral amygdala and hippocampus in social recognition in rats. Physiol Behav. 60:1996;55-63.
86. Makino S., Nishiyama M., Asaba K., Gold P.W., Hashimoto K. Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation. Am J Physiol. 275:1998;R1138-R1145.
87. Mansbach R.S., Brooks E.N., Chen Y.L. Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. Eur J Pharmacol. 323:1997;21-26.
88. Mansi J.A., Rivest S., Drolet G. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. Endocrinology. 137:1996;4619-4629.
89. Martins A.P., Marras R.A., Guimaraes F.S. Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey. Neuroreport. 8:1997;3601-3604.
90. Masuzawa M., Oki Y., Ozawa M., Watanabe F., Yoshimi T. Corticotropin-releasing factor but not urocortin is involved in adrenalectomy-induced adrenocorticotropin release. J Neuroendocrinol. 11:1999;71-74.
91. Meil W.M., See R.E. Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res. 87:1997;139-148.
92. Menzaghi F., Rassnick S., Heinrichs S., Baldwin H., Pich E.M., Weiss F., et al. The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann NY Acad Sci. 739:1994;176-184.
93. Merchenthaler I. Corticotropin-releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides. 5:1984;53-69.
94. Merchenthaler I., Vigh S., Schally A.V., Stumpf W.E., Arimura A. Immunocytochemical localization of corticotropin-releasing factor (CRF)-like immunoreactivity in the thalamus of the rat. Brain Res. 323:1984;119-122.
95. Merlo-Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., et al. Increase in extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci. 15:1995;5439-5447.
96. Mesulam M.M., Mufson E.J., Wainer B.H., Levey A.I. Central cholinergic pathways in the rar an overview based on an alternative nomenclature (Ch1-Ch6) . Neuroscience. 10:1983;1185-1201.
97. Moga M.M., Gray T.S. Evidence for corticotropin-releasing factor, neurotensin and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus. J Comp Neurol. 241:1985;275-284.
98. Moreau J.L., Kilpatrick G., Jenck F. Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport. 8:1997;1697-1701.
99. Morin S.M., Ling N., Liu X.J., Kahl S.D., Gehlert D.R. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience. 92:1999;281-291.
100. Morley J.E., Levine A.S. Corticotropin-releasing factor, grooming and ingestive behavior. Life Sci. 31:1982;1459-1464.
101. Muir J.L., Dunnett S.B., Robbins T.W., Everitt B.J. Attentional functions of the forebrain cholinergic systems effects of intaventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task . Exp Brain Res. 89:1992;611-622.
102. Muir J.L., Everitt B.J., Robbins T.W. AMPA-induced excitotoxic lesions of the basal forebrain a significant role for the cortical cholinergic system in attentional function . J Neurosci. 14:1994;2313-2326.
103. Muir J.L., Everitt B.J., Robbins T.W. The cerebral cortex of the rat and visual attentional function dissociable effects of mediofrontal, cingulate, anterior and dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task . Cerebral Cortex. 6:1996;470-481.
104. Nemeroff C.B., Owens M.J., Bissette G., Andorn A.C., Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry. 45:1988;577-579.
105. Okuyama S., Chaki S., Kawashima N., Suzuki Y., Ogawa S.I., Nakazato A., et al. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. J Pharmacol Exp Ther. 289:1999;926-935.
106. Olmstead M.C., Robbins T.W., Everitt B.J. Basal forebrain cholinergic lesions enhance conditioned approach responses to stimuli predictive of food. Behav Neurosci. 24:1998;1-27.
107. Overton P., Dean P. Detection of visual stimuli after lesions of the superior colliculus in the rat; deficit not confined to the far periphery. Behav Brain Res. 31:1988;1-15.
108. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev. 43:1991;425-473.
109. Page M.E., Berridge C.W., Foote Sl, Valentino R.J. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neurosci Lett. 164:1993;81-84.
110. Pfaff D.W., Sakuma Y. Deficits in the lordosis reflex of female rats caused by lesions in the ventromedial nucleus of the hypothalamus. J Physiol. 288:1979;203-210.
111. Plamondon H., Merali Z. Regulation of ingestion by CRF and bombesin-like peptides distinct meal-related peptide level changes . Am J Physiol. 272:1997;R268-R274.
112. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci U S A. 89:1992;4192-4196.
113. Pratt W.E., Mizumori S.J.Y. Characteristics of basolateral amygdala neuronal firing on a spatial memory task involving differential reward. Behav Neurosci. 112:1998;554-570.
114. Price M.L., Cutis A.L., Kirby L.G., Valentino R.J., Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology. 18:1998;492-502.
115. Radulovic J., Rühmann A., Liepold T., Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress differential roles of CRF receptors 1 and 2 . J Neurosci. 19:1999;5016-5025.
116. Radulovic J., Sydow S., Spiess J. Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J Neurosci Res. 54:1998;507-521.
117. Risold PY, Swanson LW (1997): Connections of the rat lateral septal complex. Brain Res Rev 24:225-195.
118. Robbins T.W., Cador M., Taylor J.R., Everitt B.J. Limbic-striatal interactions in reward-related processes. Neurosci Biobehav Rev. 13:1989;155-162.
119. Robbins T.W., Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol. 6:1996;228-236.
120. Robbins T.W., Everitt B.J., Marston H.M., Wilkinson J., Jones G.H., Page K.J. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat further implications for the role of the cholinergic neurons in the nucleus basalis in cognitive processes . Behav Brain Res. 35:1989;221-240.
121. Rodriguez de Fonseca F., Carrera M.R.A., Navarro M., Koob G.F., Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science. 749:1997;2050-2054.
122. Rolls E.T. The Brain and Emotions. 1999;Oxford University Press, Oxford.
123. Rühmann A., Bonk I., Lin C.R., Rosenfeld M.G., Spiess J. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR) development of CRFR2β-selective antisauvagine-30 . Proc Natl Acad Sci U S A. 95:1998;15264-15269.
124. Ruggiero D.A., Underwood M.D., Rice P.M., Mann J.J., Arango V. Corticotropic-releasing hormone and serotonin interact in the human brainstem behavioral implications . Neuroscience. 91:1999;1343-1345.
125. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res. 100:1999;207-215.
126. Sakamura Y., Pfaff D.W. Facilitation of female reproductive behavior from mesencephalic central grey in the rat. Am J Physiol. 237:1979;R278-R284.
127. Sakanaka M., Magari S., Shibasaki T., Lederis K. Corticotropin releasing factor-containing afferents to the lateral septum in the rat brain. J Comp Neurol. 270:1988;404-415.
128. Sakanaka M., Shibasaki T., Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 382:1986;213-238.
129. Sakanaka M., Shibasaki T., Lederis K. Corticotropin-releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidediaminobenzidine method. J Comp Neurol. 260:1987;256-298.
130. Salinas J.A., Parent M.B., McGaugh J.L. Ibotenic acid lesions of the amygdala basolateral complex or central nucleus differentially affect the response to reductions in reward. Brain Res. 742:1996;283-293.
131. Sánchez M.M., Young L.J., Plotsky P.M., Insel T.R. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol. 408:1999;365-377.
132. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., Telegdy G. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res. 675:1995;89-97.
133. Sauvage M., Holsboer F., Steckler T. Expression of corticotropin-releasing hormone receptors on brain cholinergic neurons. Soc Neurosci Abstr. 25:1999;2220.
134. Schulz D.W., Mansbach R.S., Sprouse J., Baselton J.P., Collins J., Corman M., et al. CP-154,526 a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors . Proc Natl Acad Sci U S A. 93:1996;10477-10482.
135. Shaham Y., Erb S., Keubg S., Buczek Y., Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology. 137:1998;184-190.
136. Shaham Y., Funk D., Erb S., Brown T.G., Walker C.D., Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking rats. J Neurosci. 17:1997;2605-2614.
137. Sirinathsinghji D.J., Rees L.H., Rivier J., Vale W. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature. 305:1983;232-235.
138. Skutella T., Probst J.C., Renner U., Holsboer F., Behl C. Corticotropin-releasing hormone receptor (Type I) antisense targeting reduces anxiety. Neuroscience. 85:1998;795-805.
139. Smagin G.N., Howell L.A., Ryan D.H., De Souza E.B., Harris R.B. The role of CRH2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Neuroreport. 9:1998;1601-1606.
140. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., et al. Corticotropin-releasing factor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 20:1998;1093-1102.
141. Soubrie P (1986): Reconciling the role of the central serotonin neurons in human and animal behavior. Behav Brain Sci 9:319-364. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W, et al (1996): Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273:1561-1564.
142. Soubrie P (1986): Reconciling the role of the central serotonin neurons in human and animal behavior. Behav Brain Sci 9:319-364. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W, et al (1996): Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273:1561-1564.
143. Steckler T., Holsboer F., Wurst W. Reduced attention in mice lacking a functional corticotropin-releasing hormone receptor 1. Soc Neurosci Abstr. 25:1999;606.
144. Steckler T., Inglis W., Winn P., Sahgal A. The pedunculopontine tegmental nucleus a role in cognition? Brain Res Rev. 19:1994;298-318.
145. Steckler T., Sahgal A. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res. 67:1995;165-199.
146. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice a genetic model of anxiogenic behavior . J Neurosci. 14:1994;2579-2584.
147. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain an immunohistochemical study . Neuroendocrinology. 36:1983;165-186.
148. Swanson L.W., Simmons D.M. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus a hybridization histochemical study in the rat . J Comp Neurol. 285:1989;413-435.
149. Swanson L.W., Simmons D.M. Corticosterone produces increased levels of CRF mRNA in the amygdala like it does neurotransmitter CRF cells in the PVN, while it produces major decreases in the neurohormonal cells in the parvicellular PVN. J Comp Neurol. 285:1989;413-435.
150. Takahashi K., Totsune K., Sone M., Murakami O., Satoh F., Arihara Z., et al. Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides. 19:1998;643-647.
151. Tazi A., Swerdlow N.R., Le Moal M., Rivier J., Vale W., Koob G.F. Behavioral activation by CRF evidence for the involvement of the ventral forebrain . Life Sci. 41:1987;41-49.
152. Tershner S.A., Helmstetter F.J. Injections of corticotropin-releasing factor into the periaqueductal grey enhance pavlovian fear conditioning. Psychobiology. 24:1996;49-56.
153. Timofeeva E., Richard D. Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats. Neuroendocrinology. 66:1997;327-340.
154. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M.H.M., Stalla G.K., et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genet. 19:1998;162-166.
155. Turnbull A.V., Vaughan J., Rivier J.E., Vale W.W., Rivier C. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat. Endocrinology. 140:1999;71-78.
156. Usher M., Cohen J.D., Servan-Schreiber D., Rajkowski J., Aston-Jones G. The role of locus coeruleus in the regulation of cognitive performance. Science. 283:1999;549-554.
157. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
158. Valentino R.J., Foote S.L., Page M.E. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann NY Acad Sci. 697:1993;173-188.
159. Van Bockstaele E.J., Colago, Valentino R.J. Corticotropine-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may preferentially modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol. 364:1996;523-534.
160. Van Bockstaele E.J., Colago E.E.O., Valentino R.J. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites substrate for the co-ordination of emotional and cognitive limbs of the stress response . J Neuroendocrinol. 10:1998;743-757.
161. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
162. Vazdarjanova A., McGaugh J.L. Basolateral amygdala is not critical for cognitive memory of contextual fear conditioning. Proc Natl Acad Sci U S A. 95:1998;15003-15007.
163. Vouimba R.M., Garcia R., Jaffard R. Opposite effects of lateral septal LTP and lateral septal lesions on contextual fear conditioning in mice. Behav Neurosci. 112:1998;875-884.
164. Wang H.L., Wayner M.J., Chai C.Y., Lee E.H.Y. Corticotrop-in-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur J Neurosci. 10:1998;3428-3437.
165. Webster E.L., Lewis D.B., Torpy D.J., Zachman E.K., Rice K.C., Chrousos G.P. In vivo and in vitro characterization of antalarmin, a nonpeptide
166. Wong M.L., Al-Shekhlee A., Bongiorno P.B., Esposito A., Khatri P., Sternberg E.M., et al. Localization of urocortin messenger RNA in rat brain and pituitary. Mol Psychiatry. 1:1998;307-312.
167. Wu H.C., Chen K.Y., Lee W.Y., Lee E.H. Antisense oligonucleotides to corticotropin-releasing factor impair memory retention and increase exploration in rats. Neuroscience. 78:1997;147-153.